Assembly Biosciences, Inc.

ASMB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$38,344$19,841$52,418$45,627
Short-Term Investments$73,735$110,406$39,192$101,000
Receivables$400$43$944$336
Inventory$0-$3,197$0$0
Other Curr. Assets$3,024$6,694$4,413$7,241
Total Curr. Assets$115,503$133,787$96,967$154,204
Property Plant & Equip (Net)$3,353$2,724$3,938$7,181
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$27,972
Tax Assets$0$0$0$0
Other NC Assets$312$312$889$1,703
Total NC Assets$3,665$3,036$4,827$36,856
Other Assets$0$0$0$0
Total Assets$119,168$136,823$101,794$191,060
Liabilities
Payables$585$461$2,493$2,659
Short-Term Debt$461$1,220$3,364$3,151
Tax Payable$0$0$0$0
Deferred Revenue$37,622$30,915$0$0
Other Curr. Liab.$9,135$6,629$10,439$10,263
Total Curr. Liab.$47,803$39,225$16,296$16,073
LT Debt$2,628$1,122$101$3,325
Deferred Rev, NC$0$55,379$0$2,733
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$35,378$0$2,733$0
Total NC Liab.$38,006$56,501$2,834$6,058
Other Liabilities$0$0$0$0
Cap. Leases$3,089$2,342$3,465$6,476
Total Liabilities$85,809$95,726$19,130$22,131
Equity
Pref Stock$0$0$0$0
Common Stock$7$5$4$48
Retained Earnings-$825,925-$785,748-$724,520-$631,428
AOCI-$211-$81-$803-$419
Other Equity$859,488$826,921$807,983$800,728
Total Equity$33,359$41,097$82,664$168,929
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$119,168$136,823$101,794$191,060
Net Debt-$35,255-$17,499-$48,953-$39,151
Assembly Biosciences, Inc. (ASMB) Financial Statements & Key Stats | AlphaPilot